SCHEMBL9127299

SCHEMBL9127299

O=C(Nc1ccc(NC(=O)c2cc3ccccc3[nH]2)cc1)OCc1ccccc1

nearest known ligand 0.67

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 2/20 0.67
RAB9A P51151 2/20 0.67
LMNA P02545 1/20 0.67
SMN1; SMN2 Q16637 1/20 0.67
EGFR P00533 7/20 0.62
PIK3CA P42336 7/20 0.62
PDK1 Q15118 1/20 0.55
KDM1A O60341 1/20 0.53
RCOR1 Q9UKL0 1/20 0.53
KDM4E B2RXH2 1/20 0.52
ALDH1A1 P00352 1/20 0.52
GAA P10253 1/20 0.52
MAPK1 P28482 1/20 0.52
POLB P06746 1/20 0.52
IDO1 P14902 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9127304 0.88 CCKAR (0.60) NPC1RAB9ALMNASMN1; SMN2
SCHEMBL8985906 0.82 SRD5A2 (0.60) NPC1RAB9ASMN1; SMN2KDM4EALDH1A1
SCHEMBL29475123 0.82 NPC1 (1.00) NPC1RAB9ALMNASMN1; SMN2EGFR
SCHEMBL7208136 0.82 NPC1 (1.00) NPC1RAB9ALMNASMN1; SMN2EGFR
Hydrochloric Acid SCHEMBL16465542 0.80 NPC1 (0.97) NPC1RAB9ALMNASMN1; SMN2EGFR
SCHEMBL8769590 0.79 NPC1 (0.82) NPC1RAB9ALMNASMN1; SMN2EGFR
SCHEMBL6816854 0.78 NPC1 (0.67) NPC1RAB9ALMNASMN1; SMN2EGFR
SCHEMBL30741601 0.78 IDO1 (0.61) NPC1RAB9ALMNASMN1; SMN2KDM4E
SCHEMBL3964905 0.78 IDO1 (0.61) NPC1RAB9ALMNASMN1; SMN2KDM4E
SCHEMBL8985820 0.77 MMP13 (0.68) NPC1RAB9ALMNASMN1; SMN2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5395849-A Hybrid antitumor compounds containing a cyclic enediyne and a DNA-binder BRISTOL-MYERS SQUIBB COMPANY (US) 1995-03-07 US disclosed